Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash flows from operating activities:
Net loss	$ (59,838)	$ (47,647)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	1,062	799
Share-based compensation	8,415	2,310
Interest expense from contingent beneficial conversion feature	0	26,061
Preferred stock warrant liability adjustment	0	5,578
Common stock warrant liability adjustment	(4,802)	(5,792)
Gain on loan forgiveness	0	(2,098)
Other adjustments, net	2,140	982
Changes in assets and liabilities:
Accounts receivable	(10,691)	(14,750)
Prepaid expenses and other assets	6,068	(5,000)
Inventory	(6,161)	(2,397)
Accounts payable and accrued and other expenses	(6,901)	6,857
Other, net	(847)	394
Net cash used in operating activities	(71,555)	(34,703)
Cash flows from investing activities
Purchase of property and equipment	(480)	(883)
Purchase of intangible assets	(923)	(677)
Net cash used in investing activities	(1,403)	(1,560)
Cash flows from financing activities
Proceeds from short-term borrowings	35,892	13,708
Payments of short-term borrowings	(30,929)	(8,667)
Proceeds from long-term borrowings	0	5,000
Payments of long-term borrowings	(4,500)	0
Proceeds from reverse capitalization and PIPE financing, net of $0 and $11,836, respectively, of transaction costs	0	133,663
Payments for cash payout of stock options as a result of the Merger	0	(9,890)
Other, net	615	336
Net cash provided by financing activities	1,078	134,150
Net change in cash and cash equivalents	(71,880)	97,887
Cash and cash equivalents at beginning of period	95,054	17,009
Cash and cash equivalents at end of period	$ 23,174	$ 114,896